Role of histamine in modulating the immune response and inflammation

ACCC Branco, FSY Yoshikawa… - Mediators of …, 2018 - Wiley Online Library
Inflammatory mediators, including cytokines, histamine, bradykinin, prostaglandins, and
leukotrienes, impact the immune system, usually as proinflammatory factors. Other …

Exploiting poly (I: C) to induce cancer cell apoptosis

F Bianchi, S Pretto, E Tagliabue, A Balsari… - Cancer biology & …, 2017 - Taylor & Francis
ABSTRACT TLR3 belong to the Toll-like receptors family, it is mainly expressed on immune
cells where it senses pathogen-associated molecular patterns and initiates innate immune …

[HTML][HTML] The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1

H Li, Y Xiao, Q Li, J Yao, X Yuan, Y Zhang, X Yin… - Cancer cell, 2022 - cell.com
Reinvigoration of antitumor immunity remains an unmet challenge. Our retrospective
analyses revealed that cancer patients who took antihistamines during immunotherapy …

Histamine receptors and cancer pharmacology: an update

NA Massari, MB Nicoud… - British journal of …, 2020 - Wiley Online Library
In the present review, we will discuss the recent advances in the understanding of the role of
histamine and histamine receptors in cancer biology. The controversial role of the …

[HTML][HTML] Pathophysiological roles of histamine receptors in cancer progression: implications and perspectives as potential molecular targets

PL Nguyen, J Cho - Biomolecules, 2021 - mdpi.com
High levels of histamine and histamine receptors (HRs), including H1R~ H4R, are found in
many different types of tumor cells and cells in the tumor microenvironment, suggesting their …

[HTML][HTML] Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine

I Fritz, P Wagner, H Olsson - Translational oncology, 2021 - Elsevier
Background We have previously shown an association with substantially improved survival
in breast cancer and melanoma for desloratadine and loratadine users, and set out to find …

[HTML][HTML] Combinations of calcitriol with anticancer treatments for breast cancer: an update

M Segovia-Mendoza, J García-Quiroz, L Díaz… - International journal of …, 2021 - mdpi.com
Preclinical, clinical, and epidemiological studies indicate that vitamin D3 (VD) deficiency is a
risk factor for the development of breast cancer. Underlying mechanisms include the ability …

Histamine in cancer immunology and immunotherapy. Current status and new perspectives

MP Sarasola, MA Taquez Delgado… - Pharmacology …, 2021 - Wiley Online Library
Cancer is the second leading cause of death globally and its incidence and mortality are
rapidly increasing worldwide. The dynamic interaction of immune cells and tumor cells …

[HTML][HTML] Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy

B Fendl, AS Berghoff, M Preusser, B Maier - ESMO open, 2023 - Elsevier
Highlights•Single-cell sequencing reveals enormous macrophage complexity.•Strong
functional imprinting of tumor-associated macrophages by tumor microenvironment.• …

[HTML][HTML] Psychotropic drugs show anticancer activity by disrupting mitochondrial and lysosomal function

M Varalda, A Antona, V Bettio, K Roy… - Frontiers in …, 2020 - frontiersin.org
Background and Purpose: Drug repositioning is a promising strategy for discovering new
therapeutic strategies for cancer therapy. We investigated psychotropic drugs for their …